Retail & Wholesale » Retail | New Ray Medicine International Holding Ltd.

New Ray Medicine International Holding Ltd. | Income Statement

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
192,854.00
206,928.00
252,985.00
225,388.00
235,248.00
372,441
Cost of Goods Sold (COGS) incl. D&A
142,219.00
145,751.00
187,359.00
190,987.00
177,844.00
319,043
Gross Income
50,635.00
61,177.00
65,626.00
34,401.00
57,404.00
53,398
SG&A Expense
10,985.00
19,267.00
34,911.00
41,385.00
53,417.00
52,855
EBIT
39,650.00
41,910.00
30,715.00
6,984.00
3,987.00
543
Unusual Expense
-
-
10,747.00
15,366.00
134,070.00
2,696
Non Operating Income/Expense
10,618.00
338.00
919.00
4,901.00
15,519.00
18,919
Interest Expense
1,526.00
-
-
110.00
162.00
-
Pretax Income
28,724.00
43,858.00
20,652.00
26,149.00
113,889.00
18,978
Income Tax
11,321.00
14,177.00
15,259.00
6,750.00
10,623.00
5,993
Equity in Affiliates
-
-
9,411.00
12,441.00
19,500.00
20,219
Consolidated Net Income
17,403.00
29,681.00
14,804.00
20,458.00
105,012.00
33,204
Net Income
17,403.00
29,681.00
14,804.00
20,458.00
105,012.00
33,204
Net Income After Extraordinaries
17,403.00
29,681.00
14,804.00
20,458.00
105,012.00
33,204
Net Income Available to Common
17,403.00
29,681.00
14,804.00
20,458.00
105,012.00
33,204
EPS (Basic)
0.13
0.17
0.06
0.05
0.07
0.02
Basic Shares Outstanding
135,691.30
178,138.60
256,605.50
375,226.60
1,454,383.00
1,671,847
EPS (Diluted)
0.13
0.17
0.06
0.05
0.07
0.02
Diluted Shares Outstanding
135,691.30
178,138.60
256,605.50
375,226.60
1,454,383.00
1,671,847
EBITDA
41,060.00
43,083.00
33,302.00
644.00
7,825.00
4,363
Non-Operating Interest Income
1,218.00
849.00
1,603.00
376.00
699.00
1,032

About New Ray Medicine International Holding

View Profile
Address
B-C, 37th Floor
Hangzhou Zhejiang 311112
China
Employees -
Website http://www.newraymedicine.com
Updated 07/08/2019
New Ray Medicine International Holding Ltd. is an investment company, which engages in the distribution and trading of pharmaceutical products. It operates through the following business segments: Injection Drugs; Capsule and Granule Drugs; Tablet Drugs; Marketing and Promotion Services; and Others. The Injection Drugs segment includes the trading of injection drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.